*Department of Pathology, Charles University, Faculty of Medicine in Plzen
†Molecular and Genetic Laboratory, Biopticka Laboratory Ltd, Plzen
‡‡The Fingerland Department of Pathology, Charles University, Faculty of Medicine and University Hospital, Hradec Kralove, Czech Republic
‡Department of Pathology, Toulouse University Hospital
§INSERM U1037, Cancer Research Center of Toulouse (CRCT), Toulouse
§§Department of Pathology, G. Pompidou Hospital, Paris, APHP, Paris Descartes University, Paris, France
∥Department of Pathology, UT Southwestern Medical Center, Dallas, TX
¶Department of Pathology, University Health Network, Toronto, ON, Canada
#Southern California Permanente Medical Group, Woodland Hills, CA
**Histopathology Department, Addenbrooke Hospital, Cambridge University Hospitals NHS Trust, Cambridge, UK
††Department of Pathology, IRCCS San Raffaele Scientific Institute, Milan, Italy
∥∥Department of Oral Pathology, Faculty of Dentistry, University of São Paulo, São Paulo, Brazil
The preliminary results of the study were presented as a platform presentation at USCAP Meeting 2018, Vancouver, Canada, March 17-22, 2018 (A.S.).
Conflicts of Interest and Source of Funding: Supported in parts by the grant SVV–2018 No. 260 391 provided by the Ministry of Education Youth and Sports of the Czech Republic. The authors have disclosed that they have no significant relationships with, or financial interest in, any commercial companies pertaining to this article.
Correspondence: Alena Skálová, MD, PhD, Sikl’s Department of Pathology, Medical Faculty of Charles University, Faculty Hospital, E. Benese 13, Plzen 305 99, Czech Republic (e-mail: [email protected]).
